Effect of synbiotic in treatment of diabetes

Phase 3

Recruiting

• Conditions: Type 1 diabetes.; Type 1 diabetes mellitus without complications; E10.9

• Registration Number: IRCT20220313054269N1
• Lead Sponsor: Islamic Azad University, Science and Research Branch

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

Girls and Boys 4-18 Years
Being Treated with Injectable Insulin
Fasting Blood Sugar (FBS) = 126 mg/dl
Glucose, 2 hour Post Prandial (2hpp) = 200 mg/dl
Glycated Hemoglobin (HbA1c) = 6.5%
Blood Sugar (BS) = 200 mg/dl Along with Polydipsia and Polyuria

Exclusion Criteria

Taking antibiotics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), immunosuppressants during the last month
Taking products containing probiotics and synbiotics in the last month
Metabolic disease
Gastrointestinal disease
Cardiovascular disease (CVD)
Renal disease

Study & Design

• Study Type: interventional
• Study Design: Not specified